Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
Dihydroergocryptine chemical structure | |
IUPAC name | |
CAS number 25447-66-9 |
ATC code |
PubChem 114948 |
DrugBank [1] |
Chemical formula | {{{chemical_formula}}} |
Molecular weight | 577.715 g/mol |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Pregnancy category | |
Legal status | |
Routes of administration |
Dihydroergocryptine (dihydroergocryptine mesylate) is a dopamine agonist.
Anti-parkinson drugs: dopaminergic agents (N04B) | |
---|---|
Dopa and derivatives |
Levodopa, Melevodopa, Etilevodopa |
Adamantane derivatives | |
Dopamine agonists |
Apomorphine, Bromocriptine, Cabergoline, Dihydrexidine, Dihydroergocryptine mesylate, Fenoldopam, Lisuride, Pergolide, Piribedil, Pramipexole, Quinpirole, Ropinirole, Rotigotine, SKF 38393, SKF 82958 |
MAOIs | |
Other |
Tolcapone, Entacapone, Budipine |
This page uses Creative Commons Licensed content from Wikipedia (view authors). |